The role of pharmacogenetics in the new ESMO colorectal cancer guidelines. - PubMed - NCBI

The role of pharmacogenetics in the new ESMO colorectal cancer guidelines. - PubMed - NCBI

Pharmacogenomics. 2017 Feb;18(3):197-200. doi: 10.2217/pgs-2016-0191. Epub 2017 Jan 23.

The role of pharmacogenetics in the new ESMO colorectal cancer guidelines.

Schirripa M1, Procaccio L1, Lonardi S1, Loupakis F1.

Author information

KEYWORDS:

DPD; ERCC1; UGT; colorectal cancer; pharmacogenetic

PMID:

 

28112993

 

DOI:

 

10.2217/pgs-2016-0191

[PubMed - in process] 

Free full text